Status:
UNKNOWN
Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution
Lead Sponsor:
Biosyn
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
This study will assess the distribution of topical gel in the human vagina, using enhanced MRI techniques. The number and size of uncovered areas will be studied, and the upper genital tract will be e...
Detailed Description
This study will assess the distribution of topical gel in the human vagina, using enhanced MRI techniques. The number and size of uncovered areas will be studied, and the upper genital tract will be e...
Eligibility Criteria
Inclusion
- 18 to 45 year old women
- not pregnant
- willingness to use effective method of contraception
- regular menstrual cycle
- normal Pap test result
Exclusion
- abnormal pelvic exam
- pregnant or breastfeeding
- claustrophobia or other MRI contraindications
- hypertension, hemolytic anemia,latex allergy
- history of hemorrhoids or irritable bowel syndrome
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00260767
Last Update
December 2 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Research Unit, U of Penn Medical Center
Philadelphia, Pennsylvania, United States, 19104